Report : Europe Arterial Blood Gas Kits Market Forecast to 2030 –Regional Analysis – by Product (Luer Lock Syringe and Luer Slip Syringe), Type (Non-Vented and Vented), Usage (Pre-set plunger mode and Manual Aspiration), Application (In vitro diagnostics, Electrolyte Analysis, and pH blood gas), Needle Gauge (23 G to 25 G and Less than 23 G), Syringe Volume (1 ml, 3 ml, and Others), and End User (Hospitals, Clinics, and Others)
At 7.0% CAGR, the Europe Arterial Blood Gas Kits Market is Speculated to be Worth US$ 354.83 million by 2030, says The Business Market Insights
According to the Business Market Insights’ research, the Europe arterial blood gas kits market was valued at US$ 206.02 million in 2022 and is expected to reach US$ 354.83 million by 2030, registering a CAGR of 7.0% from 2022 to 2030. Increasing prevalence of respiratory diseases and growing prevalence of metabolic and kidney diseases are the critical factors attributed to the Europe arterial blood gas kits market expansion.
Arterial blood gas tests are used to detect an acid–base imbalance that can cause kidney failure; heart failure; and metabolic diseases, such as diabetes. Thus, the test is prescribed to people suffering from metabolic and kidney diseases. As per the report titled “Global and regional diabetes prevalence estimate for 2019 and projections for 2030 and 2045’, the prevalence of diabetes is estimated to be 9.3% (463 million) across the world in 2019, rising to 10.2% (578 million) and 10.9% (700 million) by 2030 and 2045, respectively. Additionally, as per Kidney Care UK, the UK records ∼ 20 cases of kidney failure daily. It also mentions that the country reports ∼40–45,000 premature deaths every year due to CKD. Thus, the high prevalence of metabolic and kidney diseases drives the growth of the arterial blood gas kits market.
On the contrary, risks, complications, and sampling errors associated with arterial blood sampling hurdles the growth of Europe arterial blood gas kits market.
Based on product, the Europe arterial blood gas kits market is segmented into luer lock syringe and luer slip syringe. The luer lock syringe segment held 76.1% share of Europe arterial blood gas kits market in 2022, amassing US$ 156.68 million. It is projected to garner US$ 283.95 million by 2030 to expand at 7.7% CAGR during 2022–2030.
Based on type, the Europe arterial blood gas kits market is segmented into vented and non-vented. The non-vented segment held 79.1% share of Europe arterial blood gas kits market in 2022, amassing US$ 163.01 million. It is projected to garner US$ 287.82 million by 2030 to expand at 7.4% CAGR during 2022–2030.
Based on usage, the Europe arterial blood gas kits market is segmented into pre-set plunger mode and manual aspiration. The pre-set plunger mode segment held 82.7% share of Europe arterial blood gas kits market in 2022, amassing US$ 170.40 million. It is projected to garner US$ 304.81 million by 2030 to expand at 7.5% CAGR during 2022–2030.
Based on application, the Europe arterial blood gas kits market is segmented into In vitro diagnostics, electrolyte analysis, and pH blood gas. The In vitro diagnostics segment held 43.3% share of Europe arterial blood gas kits market in 2022, amassing US$ 89.23 million. It is projected to garner US$ 160.70 million by 2030 to expand at 7.6% CAGR during 2022–2030.
Based on needle guage, the Europe arterial blood gas kits market is segmented into 23 G to 25 G and less than 23 G. The 23 G to 25 G segment held 73.1% share of Europe arterial blood gas kits market in 2022, amassing US$ 150.59 million. It is projected to garner US$ 266.40 million by 2030 to expand at 7.4% CAGR during 2022–2030.
Based on syringe volume, the Europe arterial blood gas kits market is segmented into 1ml, 3ml, and others. The 3 ml segment held 45.7% share of Europe arterial blood gas kits market in 2022, amassing US$ 94.16 million. It is projected to garner US$ 166.36 million by 2030 to expand at 7.4% CAGR during 2022–2030.
Based on end user, the Europe arterial blood gas kits market is segmented into hospitals, clinics, and others. The hospitals segment held 52.0% share of Europe arterial blood gas kits market in 2022, amassing US$ 107.14 million. It is projected to garner US$ 186.47 million by 2030 to expand at 7.2% CAGR during 2022–2030.
Based on country, the Europe arterial blood gas kits market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 26.5% share of Europe arterial blood gas kits market in 2022. It was assessed at US$ 54.60 million in 2022 and is likely to hit US$ 95.31 million by 2030, exhibiting a CAGR of 7.2% during 2022–2030.
Key players operating in the Europe arterial blood gas kits market are Becton Dickinson and Co, Cardinal Health Inc, Fisher Scientific International, Inc, ICU Medical Inc, ITL health Group Ltd, Medline Industries LP, Radiometer Medical ApS, Siemens Healthineers AG, Teleflex Inc, and Vyaire Medical Inc among others.
- In April 2022, Siemens Healthineers has received U.S. Food and Drug Administration approval for RAPIDPoint 500e Blood Gas Analyzer. RAPIDLyte Arterial Sampling Syringes and RAPIDLyte Multicap Capillaries offered by Siemens are compatible with RAPIDPoint 500e Blood Gas System. This product approval strengthens the market position of the company.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com